Anvisa prohibits import and sale of Paraguayan slimming pen T36
Health agency bans tirzepatide-based product that was circulating in messaging groups without registration or proof of safety in Brazil
TL;DR
- Anvisa has banned the import, storage, distribution, sale, advertising, and use of the Paraguayan slimming pen T36.
- The T36 was marketed in Brazil as a clandestine alternative to tirzepatide, the active ingredient in the approved medication Mounjaro.
- The pen is manufactured by Paraguayan laboratory Catedral, also responsible for Tirzedral, another previously banned tirzepatide product.
- While approved in Paraguay for diabetes and weight control, T36 lacks formal equivalence and safety verification in Brazil.
- Independent studies and Anvisa highlight concerns about potential impurities, contaminants, and lack of documented manufacturing practices.
- Anvisa and Paraguay's Dinavisa have signed a cooperation agreement to combat clandestine products and exchange information.